Newland Pharmaceutical Co., Ltd. (SHE:301277)
China · Delayed Price · Currency is CNY 11.19
-0.35 (-3.03%)
At close: Aug 20, 2026
Newland Pharmaceutical Revenue
Newland Pharmaceutical had revenue of 206.95M CNY in the quarter ending March 31, 2026, a decrease of -5.84%. This brings the company's revenue in the last twelve months to 659.54M, down -13.41% year-over-year. In the year 2025, Newland Pharmaceutical had annual revenue of 672.38M, down -7.44%.
Revenue (ttm)
659.54M
Revenue Growth
-13.41%
P/S Ratio
6.65
Revenue / Employee
672.31K
Employees
981
Market Cap
4.39B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 672.38M | -54.06M | -7.44% |
| Dec 31, 2024 | 726.44M | 75.00M | 11.51% |
| Dec 31, 2023 | 651.44M | 24.07M | 3.84% |
| Jan 1, 2023 | 627.36M | 113.53M | 22.09% |
| Jan 1, 2022 | 513.84M | 80.71M | 18.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Jianmin Pharmaceutical Group | 3.18B |
| Jinling Pharmaceutical Company | 3.16B |
| Hunan Fangsheng Pharmaceutical | 1.79B |
| Henan Taloph Pharmaceutical Stock Co.,Ltd | 1.78B |
| Fuan Pharmaceutical (Group) | 1.68B |
| Tianjin Lisheng Pharmaceutical | 1.35B |
| Hunan Hansen Pharmaceutical | 1.03B |
| Qianjiang Yongan Pharmaceutical | 847.91M |